172 results on '"Rubio, Justin P."'
Search Results
2. Evidence for the role of FMR1 gray zone alleles as a risk factor for parkinsonism in females
3. Background and Breakthrough Opioid Choice May Determine Different Pain Outcomes
4. Do CYP2D6 genotypes affect oxycodone dose, pharmacokinetics, pain, and adverse effects in cancer?
5. Effect of gene variants on opioid dose, pain and adverse effect outcomes in advanced cancer: an explorative study
6. Exome array analysis suggests an increased variant burden in families with schizophrenia
7. Opioid Switch Dosing in Chronic Cancer Pain: A Prospective Longitudinal Study.
8. Estimation of the Antirelapse Efficacy of Tafenoquine, Using Plasmodium vivax Genotyping
9. Data from Saliva-Derived DNA Performs Well in Large-Scale, High-Density Single-Nucleotide Polymorphism Microarray Studies
10. Supplementary Figures 1-5, Supplementary Tables 1-3, Full List of Authors and Affiliations from Saliva-Derived DNA Performs Well in Large-Scale, High-Density Single-Nucleotide Polymorphism Microarray Studies
11. SIRT1 Activates MAO-A in the Brain to Mediate Anxiety and Exploratory Drive
12. The mutational landscape of single neurons and oligodendrocytes reveals evidence of inflammation-associated DNA damage in multiple sclerosis
13. Leptin’s metabolic and immune functions can be uncoupled at the ligand/receptor interaction level
14. Effects of enzyme inducers efavirenz and tipranavir/ritonavir on the pharmacokinetics of the HIV integrase inhibitor dolutegravir
15. Common variation in the MOG gene influences transcript splicing in humans
16. Transcriptomic effects of rs4845604, an IBD and allergy-associated RORC variant, in stimulated ex vivo CD4+ T cells
17. CD127 immunophenotyping suggests altered CD4 + T cell regulation in primary progressive multiple sclerosis
18. Analysis of extended HLA haplotypes in multiple sclerosis and narcolepsy families confirms a predisposing effect for the class I region in Tasmanian MS patients
19. Estimation of the Antirelapse Efficacy of Tafenoquine, Using Plasmodium vivax Genotyping
20. Detecting genome wide haplotype sharing using SNP or microsatellite haplotype data
21. Identifying nineteenth century genealogical links from genotypes
22. Extended haplotype analysis in the HLA complex reveals an increased frequency of the HFE-C282Y mutation in individuals with multiple sclerosis
23. Evaluation of the effect of UGT1A1 polymorphisms on dolutegravir pharmacokinetics
24. Genetic dissection of the human leukocyte antigen region by use of haplotypes of Tasmanians with multiple sclerosis
25. Deep Sequencing of The LRRK2 Gene in 14,002 Individuals Reveals Evidence of Purifying Selection and Independent Origin of the p.Arg1628pro Mutation in Europe
26. An 18-kDa Translocator Protein (TSPO) Polymorphism Explains Differences in Binding Affinity of the PET Radioligand PBR28
27. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
28. On the utility of data from the International HapMap Project for Australian association studies
29. Prevalence and clinical features of common LRRK2 mutations in Australians with Parkinsonʼs Disease
30. Genomic Organization of the Human Gα14 and Gαq Genes and Mutation Analysis in Chorea–Acanthocytosis (CHAC)
31. Histamine Receptor 3 negatively regulates oligodendrocyte differentiation and remyelination
32. Tafenoquine treatment of Plasmodium vivax malaria: suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trial
33. Estimation of the Antirelapse Efficacy of Tafenoquine, UsingPlasmodium vivaxGenotyping
34. SIRT1 Activates MAO-A in the Brain to Mediate Anxiety and Exploratory Drive
35. Leptin’s metabolic and immune functions can be uncoupled at the ligand/receptor interaction level
36. Fine mapping of multiple sclerosis susceptibility genes provides evidence of allelic heterogeneity at the IL2RA locus
37. Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20
38. Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20
39. A genomewide association study of smoking relapse in four European population-based samples
40. Deep sequencing of theLRRK2gene in 14,002 individuals reveals evidence of purifying selection and independent origin of the p.Arg1628Pro mutation in Europe
41. A genome-wide association study in progressive multiple sclerosis
42. An 18-kDa Translocator Protein (TSPO) Polymorphism Explains Differences in Binding Affinity of the PET Radioligand PBR28
43. Genetic Deficiency of Plasma Lipoprotein-Associated Phospholipase A2 (PLA2G7 V297F Null Mutation) and Risk of Alzheimer's Disease in Japan
44. CD127 immunophenotyping suggests altered CD4+ T cell regulation in primary progressive multiple sclerosis
45. Detecting genome wide haplotype sharing using SNP or microsatellite haplotype data
46. Multiple Sclerosis: A Haplotype Association Study
47. Chorea-acanthocytosis: genetic linkage to chromosome 9q21
48. McLeod neuroacanthocytosis: Genotype and phenotype
49. A conserved sorting-associated protein is mutant in chorea-acanthocytosis
50. McLeod syndrome and neuroacanthocytosis with a novel mutation in the XK gene
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.